Your browser doesn't support javascript.
loading
Liver-specific deletion of miR-181ab1 reduces liver tumour progression via upregulation of CBX7.
Chen, Jinbiao; Zhao, Yang; Zhang, Fan; Li, Jia; Boland, Jade A; Cheng, Ngan Ching; Liu, Ken; Tiffen, Jessamy C; Bertolino, Patrick; Bowen, David G; Krueger, Andreas; Lisowski, Leszek; Alexander, Ian E; Vadas, Mathew A; El-Omar, Emad; Gamble, Jennifer R; McCaughan, Geoffrey W.
Afiliação
  • Chen J; Liver Injury and Cancer Program Centenary Institute and Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2050, Australia.
  • Zhao Y; Vascular Biology Program Centenary Institute and Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2050, Australia.
  • Zhang F; School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
  • Li J; UNSW Microbiome Research Centre, School of Clinical Medicine, UNSW Medicine and Health, St George and Sutherland Clinical Campuses, Kogarah, NSW, 2217, Australia.
  • Boland JA; Vascular Biology Program Centenary Institute and Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2050, Australia.
  • Cheng NC; Centre for Motor Neuron Disease, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, 2109, Australia.
  • Liu K; Liver Injury and Cancer Program Centenary Institute and Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2050, Australia.
  • Tiffen JC; Liver Injury and Cancer Program Centenary Institute and Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2050, Australia.
  • Bertolino P; Vascular Biology Program Centenary Institute and Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2050, Australia.
  • Bowen DG; Liver Injury and Cancer Program Centenary Institute and Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2050, Australia.
  • Krueger A; Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW, 2050, Australia.
  • Lisowski L; Melanoma Epigenetics Lab Centenary Institute and Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2050, Australia.
  • Alexander IE; Liver Immunology Program Centenary Institute and Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2050, Australia.
  • Vadas MA; Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW, 2050, Australia.
  • El-Omar E; Liver Immunology Program Centenary Institute and Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2050, Australia.
  • Gamble JR; Molecular Immunology, Faculty of Biology and Chemistry, Justus Liebig University Gießen, Schubertstr 81, 35392, Giessen, Germany.
  • McCaughan GW; Institute for Molecular Medicine, Frankfurt Cancer Institute, Goethe-University, Frankfurt, Germany.
Cell Mol Life Sci ; 79(8): 443, 2022 Jul 22.
Article em En | MEDLINE | ID: mdl-35867177
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / MicroRNAs / Neoplasias Hepáticas Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / MicroRNAs / Neoplasias Hepáticas Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article